iecs.org.ar

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk

D. Spiegelman,L. C. Lovato,P. Khudyakov,T. L. Wilkens,C. A. Adebamowo,S. N. Adebamowo,L. J. Appel,J. W. Beulens,J. W. Coughlin,L. O. Dragsted,H. J. Edenberg,J. N. Eriksen,R. Estruch,D. E. Grobbee,P. E. Gulayin,V. Irazola,J. H. Krystal,M. Lazo,M. M. Murray,E. B. Rimm,I. C. Schrieks,J. D. Williamson and K. J. Mukamal. The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk Ver más »

The Kathmandu Declaration on Global CVD/Hypertension Research and Implementation Science: A Framework to Advance Implementation Research for Cardiovascular and Other Noncommunicable Diseases in Low- and Middle-Income Countries

A. Aifah,J. Iwelunmor,C. Akwanalo,J. Allison,A. Amberbir,K. P. Asante,A. Baumann,A. Brown,M. Butler,M. Dalton,V. Davila-Roman,A. L. Fitzpatrick,M. Fort,R. Goldberg,A. Gondwe,D. Ha,J. He,M. Hosseinipour,V. Irazola,J. Kamano,S. Karengera,B. M. Karmacharya,R. Koju,R. Maharjan,S. Mohan,V. Mutabazi,E. Mutimura,A. Muula,K. M. V. Narayan,H. Nguyen,B. Njuguna,M. Nyirenda,G. Ogedegbe,J. van Oosterhout,D. Onakomaiya,S. Patel,A. Paniagua-Ávila,M. Ramirez-Zea,J. Plange-Rhule,D. Roche,A. Shrestha,H. Sharma,N. Tandon,N. Thu-Cuc,A. Vaidya,R. Vedanthan and M.

The Kathmandu Declaration on Global CVD/Hypertension Research and Implementation Science: A Framework to Advance Implementation Research for Cardiovascular and Other Noncommunicable Diseases in Low- and Middle-Income Countries Ver más »

The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome

M. Gerde,E. Ibarra,R. Mac Kenzie,C. Fernandez Suarez,C. Heer,R. Alvarez,M. Iglesias,J. Balparda,E. Beruti and F. Rubinstein. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thrombosis Research. 2021;206:10.1016/j.thromres.2021.08.004.

The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome Ver más »

The health and economic burden associated with sugar-sweetened beverage consumption in Trinidad and Tobago

A. La Foucade,C. Laptiste,A. Alcaraz,K. Theodore,A. Cumberbatch,K. A. Gittens-Baynes,V. Beharry,S. Gabriel,C. Metivier,P. Edwards-Wescott and D. Bethelmie. The health and economic burden associated with sugar-sweetened beverage consumption in Trinidad and Tobago. Nutr Health. 2023:10.1177/02601060231156117.

The health and economic burden associated with sugar-sweetened beverage consumption in Trinidad and Tobago Ver más »

The global network antenatal corticosteroids trial: impact on stillbirth

R. L. Goldenberg,V. R. Thorsten,F. Althabe,S. Saleem,A. Garces,W. A. Carlo,O. Pasha,E. Chomba,S. Goudar,F. Esamai,N. F. Krebs,R. J. Derman,E. A. Liechty,A. Patel,P. L. Hibberd,P. M. Buekens,M. Koso-Thomas,M. Miodovnik,A. H. Jobe,D. D. Wallace,J. M. Belizán and E. M. McClure. The global network antenatal corticosteroids trial: impact on stillbirth. Reprod Health. 2016;13(1):10.1186/s12978-016-0174-4.

The global network antenatal corticosteroids trial: impact on stillbirth Ver más »

The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results

J. Brazier,T. Peasgood,C. Mukuria,O. Marten,S. Kreimeier,N. Luo,B. Mulhern,A. S. Pickard,F. Augustovski,W. Greiner,L. Engel,M. Belizan,Z. Yang,A. Monteiro,M. Kuharic,L. Gibbons,K. Ludwig,J. Carlton,J. Connell,S. Rand,N. Devlin,K. Jones,A. Tsuchiya,R. Lovett,B. Naidoo,D. Rowen and J. C. Rejon-Parrilla. The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results. Value in Health. 2022;25(4):https://doi.org/10.1016/j.jval.2022.01.009.

The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results Ver más »